Dr. Philip Chang, MD

Claim this profile

Cedars-Sinai Medical Center

Studies Pancreatic Cancer
Studies Motor Skills
4 reported clinical trials
6 drugs studied

Area of expertise

1

Pancreatic Cancer

Philip Chang, MD has run 1 trial for Pancreatic Cancer. Some of their research focus areas include:

Stage II
Stage IV
Stage I
2

Motor Skills

Philip Chang, MD has run 1 trial for Motor Skills. Some of their research focus areas include:

Stage II
Stage IV
Stage I

Affiliated Hospitals

Image of trial facility.

Cedars-Sinai Medical Center

Clinical Trials Philip Chang, MD is currently running

Image of trial facility.

Cyclophosphamide After Stem Cell Transplant

for Blood Cancer

The purpose of this phase 1 study is to determine the optimal dose of the immune suppressive drug, cyclophosphamide, following standard allogeneic stem cell transplant in patients aged \>/= 65 years with hematologic malignancies.

Recruiting

1 award

Phase 1

Image of trial facility.

Tart Cherry + Fish Oil

for Joint Pain

Both Tart Cherry and Omega 3 FAs have better side effect profiles compared to other commonly used medications for AIMSS, such as nonsteroidal anti-inflammatories, steroids, and serotonin norepinephrine reuptake inhibitors. Additionally, in our clinics we often find that patients tend to be more receptive to taking a supplement as opposed to an additional medication. Further, both Tart Cherry concentrate and fish oil have beneficial properties for helping with joint stiffness in general, in addition to other health issues like insomnia. There is preliminary evidence in mouse models that when given together, these supplements may have an even greater anti-inflammatory effect than when taken separately14. Although to our knowledge, no human studies have tested this hypothesis. This study has been designed to test the hypothesis that Tart Cherry and fish oil when given in combination over a 12-week period could produce beneficial changes in joint function when compared to Tart Cherry or fish oil in isolation in an obese breast cancer population experiencing AIMSS. Secondary outcomes to be assessed include pain, functional performance, quality of life and cognition.

Recruiting

1 award

Phase < 1

8 criteria

More about Philip Chang, MD

Clinical Trial Related

2 years of experience running clinical trials · Led 4 trials as a Principal Investigator · 3 Active Clinical Trials

Treatments Philip Chang, MD has experience with

  • Prehabilitation Program
  • Omega 3 FA (Fish Oil)
  • Tart Cherry
  • Cyclophosphamide
  • Personalized Self-Management Training
  • Standardized Self-Management Training

Breakdown of trials Philip Chang, MD has run

Aromatase Inhibitor Associated Musculoskeletal Symptoms

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?

What does Philip Chang, MD specialize in?

Is Philip Chang, MD currently recruiting for clinical trials?

Are there any treatments that Philip Chang, MD has studied deeply?

What is the best way to schedule an appointment with Philip Chang, MD?

What is the office address of Philip Chang, MD?

Is there any support for travel costs?